Results 151 to 160 of about 21,287 (222)

Hydroxamate-based inhibitors reveal structural determinants of selectivity for Plasmodium falciparum aminopeptidase P. [PDF]

J Biol Chem
Mills BJ, Gregory KS, Cozier GE, Taweechai S, Loughlan E, McConkey GA, Isaac RE, Foster R, Acharya KR.   +8 more
europepmc   +1 more source

ct-DNA Binding and Antibacterial Activity of Octahedral Titanium (IV) Heteroleptic (Benzoylacetone and Hydroxamic Acids) Complexes. [PDF]

Int J Med Chem, 2016
Kaushal R, Thakur S, Nehra K.
europepmc   +1 more source

HDAC inhibitors as anticancer drugs: chemical diversity, clinical trials, challenges and perspectives. [PDF]

RSC Adv
Abdallah AE.
europepmc   +1 more source

Mild and efficient synthesis of carbamates using dioxazolones as bench-stable isocyanate surrogates: application in AChE-inhibiting agent development. [PDF]

RSC Adv
Wu Y, Liu X, Zuo F, Ding Y, Kang J, Wu J, Tang W, Zhang J.   +7 more
europepmc   +1 more source

Next-Generation HDAC Inhibitors: Advancing Zinc-Binding Group Design for Enhanced Cancer Therapy. [PDF]

Cells
Hawash M.
europepmc   +1 more source

Recent Insights into the Creation of Histone Deacetylase Inhibitors for the Treatment of Human Diseases. [PDF]

Int J Mol Sci
Yudaev P, Aleksandrova Y, Neganova M.
europepmc   +1 more source

Novel Azaborine-Based Inhibitors of Histone Deacetylases (HDACs). [PDF]

Molecules
Behringer M, Schweipert M, Peters EE, Kopranovic A, Meyer-Almes FJ.   +4 more
europepmc   +1 more source

Effective Non-Invasive Delivery of Epigenetic Drugs Using Functionalized Accessory Unit Conjugates. [PDF]

Pharmaceutics
Tashima T.
europepmc   +1 more source

Metal Preference Hierarchy in the HDAC8 Active Site: A DFT Study. [PDF]

Molecules
Toshev N, Cheshmedzhieva D, Uzunova Y, Velichkov K, Dudev T.   +4 more
europepmc   +1 more source

Synthesis and <i>in vitro</i> antitumor evaluation of novel 3,4-dihydropyrimidinone-vorinostat hybrids against gastric and breast cancer cell lines. [PDF]

RSC Adv
Rios EAM, Pereira GMSDM, D'Oca MGM, Dea CM, Santos ERFB, Rampon DS, Santos LS, Nachtigall FM, Guzman L, Moore-Carrasco R, Rebolledo-Miraf D, D'Oca CRM.   +11 more
europepmc   +1 more source